Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.371, 2002-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
QOL an important endpoint among patients treated for NSCLC
Inpharma, Vol. 1, Iss. 1346, 2002-01 ,pp. :
Access to resources
Recommend
Erlotinib improves QOL in NSCLC
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 512, 2006-01 ,pp. :
Erlotinib improves QOL in NSCLC
Inpharma, Vol. 1, Iss. 1557, 2006-01 ,pp. :
Mannitol [Bronchitol] may improve mucus clearance and QOL among patients with bronchiectasis
Inpharma, Vol. 1, Iss. 1604, 2007-01 ,pp. :
QOL improves with additional SRL 172 in NSCLC
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 454, 2004-01 ,pp. :